Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-07-24

Clinical Trial Update: Study of Lumateperone in the Treatment of Patients With Bipolar Mania [Phase 3]

View source ↗

Summary

Phase 3 trial of lumateperone for Bipolar Disorder, Manic has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lumateperone (lumateperone)

Snippet

Sponsor: Intra-Cellular Therapies, Inc. | Conditions: Bipolar Disorder, Manic | Phase 3 | Status: COMPLETED